<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Caunt CJ</submitter><funding>Wellcome Trust</funding><pagination>26612-23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2546534</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>283(39)</volume><pubmed_abstract>Although many stimuli activate extracellular signal-regulated kinases 1 and 2 (ERK1/2), the kinetics and compartmentalization of ERK1/2 signals are stimulus-dependent and dictate physiological consequences. ERKs can be inactivated by dual specificity phosphatases (DUSPs), notably the MAPK phosphatases (MKPs) and atypical DUSPs, that can both dephosphorylate and scaffold ERK1/2. Using a cell imaging model (based on knockdown of endogenous ERKs and add-back of wild-type or mutated ERK2-GFP reporters), we explored possible effects of DUSPs on responses to transient or sustained ERK2 activators (epidermal growth factor and phorbol 12,13-dibutyrate, respectively). For both stimuli, a D319N mutation (which impairs DUSP binding) increased ERK2 activity and reduced nuclear accumulation. These stimuli also increased mRNA levels for eight DUSPs. In a short inhibitory RNA screen, 12 of 16 DUSPs influenced ERK2 responses. These effects were evident among nuclear inducible MKP, cytoplasmic ERK MKP, JNK/p38 MKP, and atypical DUSP subtypes and, with the exception of the nuclear inducible MKPs, were paralleled by corresponding changes in Egr-1 luciferase activation. Simultaneous removal of all JNK/p38 MKPs or nuclear inducible MKPs revealed them as positive and negative regulators of ERK2 signaling, respectively. The effects of JNK/p38 MKP short inhibitory RNAs were not dependent on protein neosynthesis but were reversed in the presence of JNK and p38 kinase inhibitors, indicating DUSP-mediated cross-talk between MAPK pathways. Overall, our data reveal that a large number of DUSPs influence ERK2 signaling. Together with the known tissue-specific expression of DUSPs and the importance of ERK1/2 in cell regulation, our data support the potential value of DUSPs as targets for drug therapy.</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Spatiotemporal regulation of ERK2 by dual specificity phosphatases.</pubmed_title><pmcid>PMC2546534</pmcid><funding_grant_id>076557</funding_grant_id><funding_grant_id>078407</funding_grant_id><funding_grant_id>062918</funding_grant_id><pubmed_authors>Norman MR</pubmed_authors><pubmed_authors>Armstrong SP</pubmed_authors><pubmed_authors>Rivers CA</pubmed_authors><pubmed_authors>McArdle CA</pubmed_authors><pubmed_authors>Caunt CJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spatiotemporal regulation of ERK2 by dual specificity phosphatases.</name><description>Although many stimuli activate extracellular signal-regulated kinases 1 and 2 (ERK1/2), the kinetics and compartmentalization of ERK1/2 signals are stimulus-dependent and dictate physiological consequences. ERKs can be inactivated by dual specificity phosphatases (DUSPs), notably the MAPK phosphatases (MKPs) and atypical DUSPs, that can both dephosphorylate and scaffold ERK1/2. Using a cell imaging model (based on knockdown of endogenous ERKs and add-back of wild-type or mutated ERK2-GFP reporters), we explored possible effects of DUSPs on responses to transient or sustained ERK2 activators (epidermal growth factor and phorbol 12,13-dibutyrate, respectively). For both stimuli, a D319N mutation (which impairs DUSP binding) increased ERK2 activity and reduced nuclear accumulation. These stimuli also increased mRNA levels for eight DUSPs. In a short inhibitory RNA screen, 12 of 16 DUSPs influenced ERK2 responses. These effects were evident among nuclear inducible MKP, cytoplasmic ERK MKP, JNK/p38 MKP, and atypical DUSP subtypes and, with the exception of the nuclear inducible MKPs, were paralleled by corresponding changes in Egr-1 luciferase activation. Simultaneous removal of all JNK/p38 MKPs or nuclear inducible MKPs revealed them as positive and negative regulators of ERK2 signaling, respectively. The effects of JNK/p38 MKP short inhibitory RNAs were not dependent on protein neosynthesis but were reversed in the presence of JNK and p38 kinase inhibitors, indicating DUSP-mediated cross-talk between MAPK pathways. Overall, our data reveal that a large number of DUSPs influence ERK2 signaling. Together with the known tissue-specific expression of DUSPs and the importance of ERK1/2 in cell regulation, our data support the potential value of DUSPs as targets for drug therapy.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Sep</publication><modification>2021-02-21T09:59:12Z</modification><creation>2019-03-27T00:16:40Z</creation></dates><accession>S-EPMC2546534</accession><cross_references><pubmed>18650424</pubmed><doi>10.1074/jbc.M801500200</doi></cross_references></HashMap>